Skip to main content

FDA recall, , Moderate risk

Baxter Novum IQ Syringe Pump

The syringe pump has a software issue that may occur during multi-syringe infusion.

What happened

Baxter Healthcare Corporation of Deerfield, Illinois, recalled the Baxter Novum IQ Syringe Pump and the Baxter Novum IQ Syringe Pump, Loaner, after the FDA identified a software issue that may occur during a Volume/Time (VOT) multi-syringe infusion when a syringe reaches empty and is replaced while a Volume To Be Infused (VTBI) remains.

The recall began August 11, 2026, and was added to the FDA's Enforcement Report on August 31, 2026. The products were distributed nationwide across 45 states, including Alaska, Alabama, Arkansas, and others. The FDA classified the recall on August 31, 2026.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

2 products

Affected if its UDI-DI is listed.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Baxter Novum IQ Syringe Pump, Loaner, Model Number 40800BAXUSL

    UDI-DI
    • 00197886002300
    Lot code
    all serial numbers
  2. Baxter Novum IQ Syringe Pump, Model Number 40800BAXUS

    UDI-DI
    • 05413765852428
    Lot code
    all serial numbers

Recall details

Company began the recall
Company
Baxter Healthcare CorporationDeerfield, Illinois
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99557
Recall numbers
Z-3065-2026 to Z-3066-2026

All recalls from Baxter Healthcare Corporation

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)